For the Inventor, By the Inventor

Enter assignee name

Abbotsford, Australia

Starpharma Pty Limited

USPTO Granted Patents = 21

CIPO Patents = 6

EPO Patents = 9

Trademarks = 2

Forward Citations = 33

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Brian Devlin Kelly (10 out of 11 patents)

David James Owen (8 out of 8 patents)

Guy Yeoman Krippner (6 out of 9 patents)

4. Peter Karellas (6 out of 6 patents)

5. Pasquale Razzino (5 out of 5 patents)

6. Scott Andrew Henderson (5 out of 5 patents)

7. Jacinth Kincaid Fairley (4 out of 4 patents)

8. Jeremy Robert Arthur Paull (4 out of 4 patents)

9. Zemin Wu (4 out of 4 patents)

10. Benjamin James Boyd (4 out of 6 patents)

11. Lisa Michelle Kaminskas (4 out of 4 patents)

12. Christopher John Hamilton Porter (4 out of 4 patents)

13. Charlotte Claire Williams (3 out of 3 patents)

14. George Holan (3 out of 25 patents)

15. Barry Ross Matthews (3 out of 11 patents)

21 patents: Sort by Forward Citations

1. 12071517 - Therapeutic dendrimer (2024-08-27),

2. 11970583 - Therapeutic dendrimer (2024-04-30),

3. 11219691 - Method of treatment or prophylaxis of infections of the eye (2022-01-11),

4. 11118016 - Therapeutic dendrimer (2021-09-14),

5. 10730999 - Dendrimer-drug conjugates (2020-08-04),

6. 10265409 - Macromolecules (2019-04-23),

7. 10149885 - Method of treatment or prophylaxis of infections of the eye (2018-12-11),

8. 9744246 - Macromolecules (2017-08-29),

9. 9585387 - PEHAM dendrimers for use in agriculture (2017-03-07),

10. 9155760 - Method of prophylaxis of bacterial vaginosis (2015-10-13),

11. 9127130 - Polylysine dendrimer contrast agent (2015-09-08),

12. 8703116 - Modified macromolecule (2014-04-22),

13. 8586705 - Macromolecular compounds having controlled stoichiometry (2013-11-19),

14. 8568753 - Delivery system (2013-10-29),

15. 8420067 - Targeted polylysine dendrimer therapeutic agent (2013-04-16),

Starpharma Pty Limited is a biotechnology company focused on the development and commercialization of innovative medical products. The company specializes in the application of dendrimer-based nanotechnology in various fields, including drug delivery, diagnostics, and personal care. Starpharma has a strong portfolio of proprietary products and technologies, with collaborations and partnerships established with leading pharmaceutical and consumer goods companies worldwide. Through its cutting-edge research and development, the company aims to improve patient outcomes and enhance the performance of existing therapeutic and diagnostic products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#1 in Abbotsford

#151 in Australia

#29,081 in the World

Abbotsford, Australia

Starpharma Pty Limited

Forward Citations = 33

38 inventors:

Brian Devlin Kelly (10 out of 11 patents)

David James Owen (8 out of 8 patents)

Guy Yeoman Krippner (6 out of 9 patents)

4. Peter Karellas (6 out of 6 patents)

5. Pasquale Razzino (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…